the cancer cells showed high rates of DNA synthesis and no signs of DNA cleavage or cell death. Once the inhibitors were washed away, these cells proliferated. The cancer cells’ survival despite a low ...

Charlene earned her MSc and PhD in cell biology from the University of Toronto ... To do this, they utilized information from The Cancer Genome Atlas Program, a publicly funded project that ...

Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and activation levels of drug targets in breast tumors. This innovative ...

Credit: Thinkstock Investigators explored the potential of a noninvasive ctDNA assay as a predictive biomarker for advanced or metastatic urothelial cancer ... of total cell-free DNA (cfDNA ...

Detailed price information for Predictive Oncology Inc (POAI-Q) from The Globe and Mail including charting and trades.